M&A Deal Summary

MorphoSys Acquires Lanthio Pharma BV

On May 7, 2015, MorphoSys acquired life science company Lanthio Pharma BV

Acquisition Highlights
  • This is MorphoSys’ 1st transaction in the Life Science sector.
  • This is MorphoSys’ 2nd transaction in the Netherlands.

M&A Deal Summary
Date 2015-05-07
Target Lanthio Pharma BV
Sector Life Science
Buyer(s) MorphoSys
Deal Type Add-on Acquisition

Target

Lanthio Pharma BV

Groningen, Netherlands
Lanthio Pharma BV is a biopharmaceutical company.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

MorphoSys

Planegg, Germany
Category Company
Founded 1992
Sector Life Science
Revenue 278M EUR (2022)
DESCRIPTION

MorphoSys is a global biopharmaceutical company developing innovative medicines in oncology. MorphoSys was formed in 1992 and is based in Planegg, Germany.

DEAL STATS #
Overall 2 of 3
Sector (Life Science) 1 of 2
Type (Add-on Acquisition) 1 of 2
Country (Netherlands) 2 of 2
Year (2015) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-10-15 Lanthio Pharma - Lanthipeptide Technology

Netherlands

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-06-02 Constellation Pharmaceuticals

Cambridge, Massachusetts, United States

Constellation Pharmaceuticals is a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics that address serious unmet medical needs in patients with various forms of cancer. Constellation Pharmaceuticals was founded in 2008 and is based in Cambridge, Massachusetts.

Buy $1.7B
Mergr

Product

Company

Legal